Can we predict who recovers best after stroke surgery?
NCT ID NCT07740018
First seen Jul 31, 2026 · Last updated Jul 31, 2026
Summary
This study looks at people who have had a severe stroke caused by a blocked large blood vessel in the brain. They will undergo a procedure to remove the clot and restore blood flow. The goal is to understand which patient characteristics, imaging findings, and procedural details are linked to better recovery and fewer complications. By identifying these factors, doctors may be able to personalize treatment and improve outcomes for future stroke patients.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- endovascular thrombectomy (mechanical clot removal)
- What this could lead to
- If successful, this could help doctors predict which stroke patients will benefit most from clot removal, leading to faster and more personalized treatment decisions.
- What could go wrong
- This is an observational study with a small number of participants, so findings may not apply to all stroke patients. It does not test a new treatment, so it cannot directly improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Aug 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * General Criteria (Applicable to All Time Windows) * Age ≥ 18 to 80 years old. * Acute ischemic stroke due to large vessel occlusion (LVO) presenting within 24 hours from symptom onset or last known well. Occlusion involving one of the following vessels: * internal carotid artery (ICA) * M1 segment of the middle cerebral artery (MCA) * A1 segment of the anterior cerebral artery (ACA) * P1 segment of the posterior cerebral artery (PCA) * Basilar artery (BA) * V4 segment of the vertebral artery (VA) * National Institutes of Health Stroke Scale (NIHSS) score ≥ 6. Patients Presenting Within 0-6 Hours from Symptom Onset or Last Known Well , * Alberta Stroke Program Early CT Score (ASPECTS) ≥ 6. Patients presenting 6-24 hours from the last known well, imaging eligibility based on : * Estimated ischemic core volume \< 70 mL. * Ratio of critically hypoperfused tissue to ischemic core (mismatch ratio) ≥ 1.8. * Absolute volume of potentially salvageable tissue (Diffusion to flair mismatch volume) ≥ 15 mL. Exclusion Criteria: * • Patients with stroke resulting from etiologies other than LVO. * Individuals with a history of previous strokes. * Hemorrhagic stroke * Large established infarction (e.g., ASPECTS \< 6 for patients within the early time window or imaging findings not meeting eligibility criteria in the late window). * Patients presenting 6-24 hours from the last known well who do not meet advanced imaging selection criteria (e.g., DEFUSE 3 or DAWN eligibility criteria). * Pre-stroke disability with a modified Rankin Scale (mRS) score ≥2. * Rapid improvement in neurological status to an NIHSS \< 6 or evidence of vessel recanalization prior to randomization.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Endovascular thrombectomy are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Sohag University Faculty of Medicine
RECRUITINGSohag, 82516, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Stroke treatment upgrade: adding a Clot-Buster after clot removal may boost recovery
- Sugar-Based gel shows promise for stroke patients in early trial
- Could a common antibiotic help stroke patients walk again?
- Could a common antibiotic boost stroke recovery? new trial aims to find out
- Brain zaps after stroke: could TMS help heal faster?